Generating protective immunity against genital herpes-Reference-Cited by-同舟云学术

Generating protective immunity against genital herpes

Published:2013-10 Issue:10 Volume:34 Page:487-494
ISSN:1471-4906
Container-title:Trends in Immunology
language:en
Short-container-title:Trends in Immunology

Author:

Shin Haina,Iwasaki Akiko

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference78 articles.

1. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection;Looker;Bull. World Health Organ.,2008

2. Seroprevalence of herpes simplex virus type 2 among persons aged 14–49 years – United States, 2005–2008;Centers for Disease Control;Morb. Mortal. Wkly. Rep.,2008

3. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials;Johnston;Lancet,2012

4. HSV-2: in pursuit of a vaccine;Johnston;J. Clin. Invest.,2011

5. HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection;Roth;Microb. Pathog.,2013

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seroprevalence and Vaginal Shedding of Herpes Simplex Virus Type 2 in Pregnant Adolescents and Young Women from Morelos, Mexico;Viruses;2023-05-08

2. NK cell-derived extracellular granzyme B drives epithelial ulceration during HSV-2 genital infection;Cell Reports;2023-04

3. Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study;Frontiers in Immunology;2023-03-16

4. Mucosal viral infection induces a regulatory T cell activation phenotype distinct from tissue residency in mouse and human tissues;Mucosal Immunology;2022-08

5. A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection;eLife;2021-05-28